Blog | HemaCare

p11 Levels Increase in Peripheral Blood Mononuclear Cells from Patients with Parkinson’s Disease

Nov 9, 2016 12:00:00 AM / by Stacy Matthews Branch, DVM, PhD posted in p11, Parkinson's disease, Parkinson's disease treatment research, PBMCs, research, stem cell research, Stem Cell Therapy

0 Comments

Depression is a common and challenging component of Parkinson’s disease (PD). Up to 70% of patients with PD experience depression. This clinical symptom is not only a result of PD, but a part of the condition itself. Study findings have shown that inflammation not only plays a part in the physical signs of PD, but is also involved in the development of depression. The increase in inflammatory mediators, such as cytokines, in PD is detectable before signs of PD begin. These mediators may serve as important biomarkers of PD that can be utilized to detect PD and allow early intervention.

Read More

Neural Stem Cell Therapy for Neurodegenerative Disorders

May 21, 2014 1:32:12 PM / by Maria posted in dopamine, Innovation, mesenchymal stem cells, neural stem cells, neurodegenerative diseases, Parkinson's disease, research, stem cell therapy, stem cells, trophic factors

0 Comments

Neural stem cells may provide long-term treatment of neurodegenerative diseases such as Parkinson's by cell replacement or trophic factor secretion.

Read More

Subscribe Here!

Posts by Topic

see all

Recent Posts